People who had submitted proposals in pursuit of patents for their pharmaceutical products have been advised to revise their proposals to exclude claims to patent the product and retain claim for process patents.
People who had submitted proposals in pursuit of patents for their pharmaceutical products have been advised to revise their proposals to exclude claims to patent the product and retain claim for process patents.
Rwanda says the government amended the law to remove pharmaceutical products from patents because the process of drug patentability requires skills, money and technology which the country lacks.
Christopher Kiige, an intellectual property consultant from Kampala, said the acute skill and capacity gaps is partly why the continent still holds onto to foreign corporations.
